 |
|
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Amaylia Oehadian, Prayudi Santoso, Dick Menzies, Rovina Ruslami
Tuberc Respir Dis. 2022;85(2):111-121. Published online 2022 Jan 20 DOI: https://doi.org/10.4046/trd.2021.0122
|
|
Citations to this article as recorded by
 Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations
Dario Cattaneo, Deborah JE Marriott, Cristina Gervasoni
Expert Review of Clinical Pharmacology.2023; 16(3): 219. CrossRef Nanosized Drug Delivery Systems to Fight Tuberculosis
Tom Bourguignon, Jesus Alfredo Godinez-Leon, Ruxandra Gref
Pharmaceutics.2023; 15(2): 393. CrossRef The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis
Brett D. Edwards, Stephen K. Field
Drugs.2022; 82(18): 1695. CrossRef
|